From: Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342
Biomarker
Race
P valuea
Caucasian
African-American
ER positive
58/109 (53%)
13/32 (41%)
0.21
HER2 positive
27/121 (22%)
3/34 (9%)
0.08
Triple negative
26/121 (21%)
16/34 (47%)
0.003